Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Veronica L Espinoza"'
Autor:
Madison M. Rose, Veronica L. Espinoza, Katelyn J. Hoff, Laura A. Pike, Vibha Sharma, Marie-Claude Hofmann, Aik Choon Tan, Nikita Pozdeyev, Rebecca E. Schweppe
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 378
Patients with advanced thyroid cancer, including advanced papillary thyroid cancer and anaplastic thyroid cancer (ATC), have low survival rates because of the lack of efficient therapies available that can combat their aggressiveness. A total of 90%
Autor:
Sharon Sams, Laura A. Pike, Veronica L Espinoza, Christopher D. Raeburn, Philip Reigan, Rebecca E. Schweppe, Daniel V. LaBarbera, Nikita Pozdeyev, Hannah M Hicks, Logan R McKenna
Publikováno v:
Molecular Carcinogenesis. 60:201-212
Mutations in the BRAF gene are highly prevalent in thyroid cancer. However, the response rate of thyroid tumors to BRAF-directed therapies has been mixed. Increasingly, combination therapies inhibiting the MAPK pathway at multiple nodes have shown pr
Publikováno v:
Cancer Research. 82:2434-2434
Advanced papillary thyroid cancer (PTC) and anaplastic thyroid cancer (ATC) are the leading causes of endocrine cancer death. Mutations in the MAP kinase (MAPK) pathway are common in PTC and ATC, especially in BRAF, with a prevalence of 40-60%. Despi
Autor:
Tugs-Saikhan Chimed, Kelsey W. Nassar, Rebecca E. Schweppe, Christophe Langouet-Astrie, Veronica L Espinoza, Stacey M. Bagby, Mayumi Fujita, Jennifer D. Hintzsche, Aik Choon Tan, Carol M. Amato, William A. Robinson
Publikováno v:
Mol Cancer Ther
There is a clear need to identify targetable drivers of resistance and potential biomarkers for salvage therapy for patients with melanoma refractory to the combination of BRAF and MEK inhibition. In this study, we performed whole-exome sequencing on